PC - Page 5

Action·Alphabet·AMD·Intel·Meta·News·NVIDIA·PC·YouTube

The AI Giant’s True Test: Is Nvidia a Steal or a Sinking Ship?

Nvidia’s GPUs drive its dominance in gaming and AI sectors, propelling the company’s stock up by over 800% recently. DeepSeek, a Chinese startup, raises investor concerns by effectively using Nvidia’s lower-performance chips, challenging Nvidia’s market projections. Nvidia’s stock valuation hits a yearly

22 February 2025

*TR·Action·Crypto·News·PC·YouTube

The Surprising Comeback Kid: How Robinhood Stormed Back from Meme Stocks to Profit Machine

Robinhood transformed from a meme stock platform to a broad financial services provider, achieving a 381% stock surge in one year. Key to its success, Robinhood offered up to 5% APY, attracting investors and increasing asset engagement sixfold among premium users. It

18 February 2025

Action·News·PC·YouTube

Pfizer’s Path Forward: Why It’s More Than a Vaccine Success Story

Pfizer experienced significant revenue growth during the pandemic, but earnings have since declined as Covid-related demand fades. Investors should consider Pfizer’s pre-pandemic revenue level of approximately $51 billion for realistic future growth expectations. By 2030, Pfizer aims to exceed $80 billion in

18 February 2025

*EN·Action·Apple·Electric Vehicles·Intel·News·Paramount·PC·Tesla

Could Elon Musk’s Business Realm Soar with a Second Trump Presidency?

Elon Musk’s businesses are positioned at a crucial intersection with potential developments in Washington. SpaceX could benefit immensely from Trump’s support and key NASA appointments. Tesla faces challenges from potential policy shifts affecting electric vehicles, despite prior successes. X has regained financial

18 February 2025

Action·Google·News·PC

The AI Stock Surge: How AppLovin Captivated Investors with Jaw-Dropping Gains

AppLovin’s stock soared over 900% in a year, driven by Axon 2 AI technology. The company excels in adtech, crucial for mobile app user acquisition and monetization. Revenue surged by 73% to $999.5 million, though legacy apps experienced a slight decline. Earnings

18 February 2025

*TR·News·PC·Quantum Computing·Rigetti Computing·YouTube

Quantum Leap or Market Dip? Rigetti Stock in the Spotlight

Rigetti Computing is at the forefront of quantum computing, aiming to revolutionize industries with its integrated platform. Recent technological advancements have sparked renewed investor interest in Rigetti’s stock. Stock fluctuations indicate both potential and risks associated with the burgeoning quantum sector. Strategic

18 February 2025

Action·Apple·News·PC·Tesla

The Untold Struggles of JELD-WEN: A Look Beyond the Revenue Beat

JELD-WEN’s Q4 2024 revenue surpassed expectations, reaching $895.7 million, 5.8% higher than analyst predictions. Despite this, the company’s revenue experienced a 12.3% decline year-on-year, indicating underlying struggles. Operating profit margins dropped to a 5.7% loss, reflecting deteriorating financial performance. Key challenges include

18 February 2025

*EN·Action·News·PC·Release·YouTube

Global Markets Dance Amid Inflation Jitters and Policy Watch

Asian markets display mixed reactions: Japan’s Nikkei 225 shows minimal change, despite robust economic growth; South Korea’s Kospi rises by 0.8%. Australian stocks fall by 0.6%, while Hong Kong’s Hang Seng and China’s Shanghai Composite show slight gains, indicating cautious optimism. In

17 February 2025

*DE·*EN·Action·Intel·Meta·News·Palantir·PC

Software Stocks Soaring: What’s Driving Innodata’s Meteoric Rise?

Software stocks are experiencing significant growth, with tech companies like Innodata Inc. (NASDAQ:INOD) gaining attention. Innodata’s expertise in AI transforms data into predictive insights, attracting investment interest and major tech clients. Financial forecasts predict a 50% revenue increase by 2025, with free

17 February 2025

Action·News·PC·Release·YouTube

These Healthcare Stocks Could Skyrocket in 2025—Here’s Why

Eli Lilly reports a significant 45% sales growth, driven largely by its diabetes drug Mounjaro, which achieved $3.5 billion in revenue. Anticipation surrounds Eli Lilly’s experimental weight loss drug, retatrutide, with trial data expected later this year. Summit Therapeutics experiences a dramatic

17 February 2025

News·Paramount·PC·YouTube

Penny Stocks in Australia: Unassuming Gems or Hidden Risks?

Investors eagerly await the Reserve Bank’s interest rate decision, influencing the Australian stock market’s atmosphere. Penny stocks captivate due to their growth potential despite their small size and inherent risks. EMVision Medical Devices garners attention for its innovative neurodiagnostic technology, maintaining a

17 February 2025